Fiche du document
- doi: 10.1038/s41590-019-0589-5
- issn: 1529-2908
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41590-019-0589-5
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32066953
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1529-2916
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B4EB98E7D7051
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Mouse House mice Mus musculus House mouseCiter ce document
H. Wang et al., « CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. », Serveur académique Lausannois, ID : 10.1038/s41590-019-0589-5
Métriques
Partage / Export
Résumé
Depleting regulatory T cells (T reg cells) to counteract immunosuppressive features of the tumor microenvironment (TME) is an attractive strategy for cancer treatment; however, autoimmunity due to systemic impairment of their suppressive function limits its therapeutic potential. Elucidating approaches that specifically disrupt intratumoral T reg cells is direly needed for cancer immunotherapy. We found that CD36 was selectively upregulated in intrautumoral T reg cells as a central metabolic modulator. CD36 fine-tuned mitochondrial fitness via peroxisome proliferator-activated receptor-β signaling, programming T reg cells to adapt to a lactic acid-enriched TME. Genetic ablation of Cd36 in T reg cells suppressed tumor growth accompanied by a decrease in intratumoral T reg cells and enhancement of antitumor activity in tumor-infiltrating lymphocytes without disrupting immune homeostasis. Furthermore, CD36 targeting elicited additive antitumor responses with anti-programmed cell death protein 1 therapy. Our findings uncover the unexplored metabolic adaptation that orchestrates the survival and functions of intratumoral T reg cells, and the therapeutic potential of targeting this pathway for reprogramming the TME.